Cn About us Company Introduction Company Introduction History Core Strengths Qualifications &Awards Our Partner Therapeutic Area CNS Disease Mental Illness Depression Disorder Anxiety Disorder Schizophrenia Neurodegenerative Disease Alzheimer's Disease (AD) Parkinson's Disease (PD) Amyotrophic Lateral Sclerosis (ALS) Pain Disorders Inflammatory Pain Neuropathic Pain Postoperative Pain Sleep and Seizure Disorders Sleep Disorder Epilepsy Brain Cancers Primary Tumor (Gliomas) Metastatic Brain Tumor Neurovasculor Disease Stroke Hypertension Addiction and Anesthesia Drug Addiction General Anesthesia Non-CNS Diseases Reproduction-Related Model Menopause-Related Model Service & Platfroms Service Pharmacokinetics (PK) Ex Vivo P-gp / BCRP Substrate Assessment System Ex Vivo Pharmacology In Vivo Pharmacodynamics (PD) CNS Safety Pharmacology Target Validatio Human Deried Stem Cell And Organoids iPS Cell-Derived Differentiated Cells Organoids Platfrom Behavioral Analysis Electrophysiology Biomarker Evaluation AI-Driven Phenotypic Screening Multi-Dimensional Surgery and Imaging In Vitro Immunological Activity Evaluation of TCE Drugs News & Events Contact us Join us
